Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 18, 2026

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
08:31

Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

Published on: October 11, 2019

Reply: To PMID 22524487

M Ydemann, L Rovsing, K S Olsen

    Acta Anaesthesiologica Scandinavica
    |September 29, 2012
    PubMed
    Summary

    No abstract available in PubMed .

    More Related Videos

    Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
    08:55

    Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

    Published on: December 14, 2017

    Related Experiment Videos

    Last Updated: May 18, 2026

    Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
    08:31

    Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine

    Published on: October 11, 2019

    Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag
    08:55

    Rab10 Phosphorylation Detection by LRRK2 Activity Using SDS-PAGE with a Phosphate-binding Tag

    Published on: December 14, 2017

    Related Concept Videos

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

    Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

    Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
    Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Commentary to Corti et al.: Exploring the utility and limitations of ChatGPT in scientific literature searches.

    ESMO real world data and digital oncology·2026
    Same author

    Global Variations in Water Vapor and Saturation State Throughout the Mars Year 34 Dusty Season.

    Journal of geophysical research. Planets·2023
    Same author

    First Results from the DEAP-3600 Dark Matter Search with Argon at SNOLAB.

    Physical review letters·2018
    Same author

    Electroconvulsive therapy as a treatment for protracted refractory delirium in the intensive care unit--five cases and a review.

    Journal of critical care·2014
    Same author

    Propofol-remifentanil or sevoflurane for children undergoing magnetic resonance imaging? A randomised study.

    Acta anaesthesiologica Scandinavica·2013
    Same author

    Problems in obtaining sufficient anaesthesia with propofol and remifentanil: three cases, a test infusion, and a review.

    British journal of anaesthesia·2012